Volume 22, No 1 (2009) | Annals of Gastroenterology

Skip to main content Skip to main navigation menu Skip to site footer

Volume 22, No 1 (2009)

Published: 2009-05-11

Table of contents

Editorial (by invitation only)

Melatonin: A potent antioxidant agent with anti-inflammatory and anti-apoptotic effects that might be useful in the treatment of IBD patients

A. Triantafillidis, J.K. Triantafillidis

10 - 12
- PDF

Reviews

Mutants in the precore, core promoter, and core regions of Hepatitis B virus, and their clinical relevance

Alexandra Alexopoulou

13 - 23
- PDF
Insights into the pathogenesis of NAFLD: The role of metabolic and pro-inflammatory mediators.

E. Xirouchakis, Penelopi Manousou, Lemonia Tsartsali, S. Georgopoulos, A.K. Burroughs

24 - 33
- PDF
Is primary biliary cirrhosis a risk factor for hepatic and extrahepatic malignancies?

Melanie Deutsch

34 - 39
- PDF

Original Articles

Palliation with Previously Gemcitabine in Patients with Advanced Pancreatic Cancer Treated with the Placement of a Covered Metal Biliary Stent

D. Xinopoulos, D. Dimitroulopoulos, A. Fotopoulou, D. Korkolis, K. Tsamakidis, D. Kypreos, S. Basioukas, S. Patsavela, A. Loukou, E. Paraskevas

40 - 45
- PDF
Effective intragastric balloon treatment in obese adolescents

T. Karagiozoglou-Lampoudi, P. Papakostas, S. Penna, G. Pyankova, K. Kotzampassi

46 - 51
- PDF

Case Reports

Synchronous Gastric Carcinoid and Gastric Adenocarcinoma with Plummer-Vinson Syndrome: A Case Report and Literature Review

N.R. Sawalakhe, S.U. Nistala, M. Sasidharan, R.T. Narendran, A.D. Amrapurkar, R.M. Joshi, P.M. Rathi

52 - 55
- PDF
Oesophageal varices in a case of compressive goiter

R. Sterpu, A. Bosquet, A. Medjkane, L. Affo, P. Vinceneux, I. MahÃ©

56 - 59
- PDF
Crohn's disease and schistostomiasis: A rare coexistence

N. Viazis, J. Vlachogiannakos, E. Komninou, K. Papaxoinis, D. Georgiadis, M. Rodias, M.E. Kopaka, D.G. Karamanolis

60 - 61
- PDF
Myocarditis due to mesalamine treatment in a patient with ulcerative colitis: Favorable outcome after Infliximab treatment

J.K. Triantafillidis, P. Cheracakis, M. Mylonaki, F. Georgopoulos, V. Panteris, G. Malgarinos, C. Malli, J. Fouskas

62 - 64
- PDF